Buzzetti R, Maddaloni E, Gaglia J, Leslie RD, Wong FS, Boehm BO. Adult-onset autoimmune diabetes. Nat Reviews Disease Primers. 2022;8:63.

Article  PubMed  Google Scholar 

Kumar A, de Leiva A. Latent autoimmune diabetes in adults (LADA) in Asian and European populations. Diab/Metab Res Rev. 2017;33.

WHO. Classification of diabetes Mellitus. WHO; 2019.

Buzzetti R, Tuomi T, Mauricio D, Pietropaolo M, Zhou Z, Pozzilli P, et al. Management of latent autoimmune diabetes in adults: a Consensus Statement from an International Expert Panel. Diabetes. 2020;69:2037–47.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chinese Endocrinologist Association CMDA. Consensus of Chinese experts on the diagnosis and treatment of latent autoimmune diabetes in adults(2021 Edition). Natl Med J China. 2021;101.

Classification and Diagnosis of Diabetes. Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45:S17–38.

Article  Google Scholar 

Vauhkonen I, Niskanen L, Knip M, Ilonen J, Vanninen E, Kainulainen S, et al. Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults. Diabetologia. 2000;43:69–78.

Article  PubMed  CAS  Google Scholar 

Cousminer DL, Ahlqvist E, Mishra R, Andersen MK, Chesi A, Hawa MI, et al. First Genome-Wide Association Study of Latent Autoimmune Diabetes in adults reveals novel insights linking Immune and metabolic diabetes. Diabetes Care. 2018;41:2396–403.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kawasaki E. Anti-islet autoantibodies in Type 1 diabetes. Int J Mol Sci. 2023;24.

Deng C, Xiang Y, Tan T, Ren Z, Cao C, Huang G, et al. Altered peripheral B-Lymphocyte subsets in type 1 diabetes and latent autoimmune diabetes in adults. Diabetes Care. 2016;39:434–40.

Article  PubMed  CAS  Google Scholar 

Tan T, Xiang Y, Deng C, Cao C, Ren Z, Huang G, et al. Variable frequencies of peripheral T-lymphocyte subsets in the diabetes spectrum from type 1 diabetes through latent autoimmune diabetes in adults (LADA) to type 2 diabetes. Front Immunol. 2022;13:974864.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schloot NC, Pham MN, Hawa MI, Pozzilli P, Scherbaum WA, Schott M, et al. Inverse relationship between organ-specific autoantibodies and systemic Immune mediators in Type 1 diabetes and type 2 diabetes: action LADA 11. Diabetes Care. 2016;39:1932–9.

Article  PubMed  CAS  Google Scholar 

Piccioni A, Rosa F, Mannucci S, Manca F, Merra G, Chiloiro S et al. Gut microbiota, LADA, and type 1 diabetes Mellitus: an evolving relationship. Biomedicines. 2023;11.

Löfvenborg JE, Ahlqvist E, Alfredsson L, Andersson T, Dorkhan M, Groop L, et al. Genotypes of HLA, TCF7L2, and FTO as potential modifiers of the association between sweetened beverage consumption and risk of LADA and type 2 diabetes. Eur J Nutr. 2020;59:127–35.

Article  PubMed  Google Scholar 

Katahira M, Tsunekawa T, Mizoguchi A, Yamaguchi M, Tsuru K, Takashima H, et al. Critical amino acid variants in HLA-DRB1 and -DQB1 allotypes in the development of classical type 1 diabetes and latent autoimmune diabetes in adults in the Japanese Population. Curr Issues Mol Biol. 2021;43:107–15.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chen W, Chen X, Zhang M, Huang Z. The association of human leukocyte antigen class II (HLA II) haplotypes with the risk of latent autoimmune diabetes of adults (LADA): evidence based on available data. Gene. 2021;767:145177.

Article  PubMed  CAS  Google Scholar 

Hernández M, Nóvoa-Medina Y, Faner R, Palou E, Esquerda A, Castelblanco E, et al. Genetics: is LADA just late onset type 1 diabetes? Front Endocrinol. 2022;13:916698.

Article  Google Scholar 

Petrone A, Bugawan TL, Mesturino CA, Nisticò L, Galgani A, Giorgi G, et al. The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region). Tissue Antigens. 2001;58:385–94.

Article  PubMed  CAS  Google Scholar 

Pang H, Luo S, Huang G, Li X, Xie Z, Zhou Z. The Association of CTLA-4 rs231775 and rs3087243 polymorphisms with latent autoimmune diabetes in adults: a Meta-analysis. Biochem Genet. 2022;60:1222–35.

Article  PubMed  CAS  Google Scholar 

Lukacs K, Hosszufalusi N, Dinya E, Bakacs M, Madacsy L, Panczel P. The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult europeans and the gene effect is modified by obesity: a meta-analysis and an individual study. Diabetologia. 2012;55:689–93.

Article  PubMed  CAS  Google Scholar 

Bakhtadze E, Cervin C, Lindholm E, Borg H, Nilsson P, Arnqvist HJ, et al. Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15–34 years) but not in middle-aged (40–59 years) diabetic patients. Diabetologia. 2008;51:2224–32.

Article  PubMed  CAS  Google Scholar 

Zampetti S, Spoletini M, Petrone A, Capizzi M, Arpi ML, Tiberti C, et al. Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5). Diabet Medicine: J Br Diabet Association. 2010;27:701–4.

Article  CAS  Google Scholar 

Andersen MK. New insights into the Genetics of Latent Autoimmune diabetes in adults. Curr Diab Rep. 2020;20:43.

Article  PubMed  Google Scholar 

Shi X, Huang G, Wang Y, Liu Z, Deng C, Li X, et al. Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA. Diabetologia. 2019;62:399–407.

Article  PubMed  CAS  Google Scholar 

Yang L, Zhou ZG, Tan SZ, Huang G, Jin P, Yan X, et al. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults. Ann N Y Acad Sci. 2008;1150:263–6.

Article  PubMed  CAS  Google Scholar 

Tiberti C, Giordano C, Locatelli M, Bosi E, Bottazzo GF, Buzzetti R, et al. Identification of tyrosine phosphatase 2(256–760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. Diabetes. 2008;57:1276–83.

Article  PubMed  CAS  Google Scholar 

Tiberti C, Zampetti S, Capoccia D, Campagna G, Lucantoni F, Anastasi E, et al. Evidence of diabetes-specific autoimmunity in obese subjects with normal glucose tolerance. Diab/Metab Res Rev. 2018;34:e3055.

Article  Google Scholar 

Hu J, Zhang R, Zou H, Xie L, Zhou Z, Xiao Y. Latent autoimmune diabetes in adults (LADA): from immunopathogenesis to Immunotherapy. Front Endocrinol. 2022;13:917169.

Article  Google Scholar 

Crudele L, Gadaleta RM, Cariello M, Moschetta A. Gut microbiota in the pathogenesis and therapeutic approaches of diabetes. EBioMedicine. 2023;97:104821.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fang Y, Zhang C, Shi H, Wei W, Shang J, Zheng R, et al. Characteristics of the gut microbiota and metabolism in patients with latent autoimmune diabetes in adults: a case-control study. Diabetes Care. 2021;44:2738–46.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Li D, Li Y, Yang S, Lu J, Jin X, Wu M. Diet-gut microbiota-epigenetics in metabolic diseases: from mechanisms to therapeutics. Volume 153. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie; 2022. p. 113290.

Aljutaily T, Consuegra-Fernández M, Aranda F, Lozano F, Huarte E. Gut microbiota metabolites for sweetening type I diabetes. Cell Mol Immunol. 2018;15:92–5.

Article  PubMed  CAS  Google Scholar 

Kim CH. Microbiota or short-chain fatty acids: which regulates diabetes? Cell Mol Immunol. 2018;15:88–91.

Article  PubMed  CAS  Google Scholar 

Mariño E, Richards JL, McLeod KH, Stanley D, Yap YA, Knight J, et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol. 2017;18:552–62.

Article  PubMed  Google Scholar 

Wen L, Wong FS. Dietary short-chain fatty acids protect against type 1 diabetes. Nat Immunol. 2017;18:484–6.

Article  PubMed  CAS  Google Scholar 

Regnell SE, Lernmark Å. Early prediction of autoimmune (type 1) diabetes. Diabetologia. 2017;60:1370–81.

Article  PubMed  PubMed Central  CAS